In a 47‑year‑old woman with anxiety, insomnia, worsening migraines, a normal brain MRI, and a low estradiol level of 23 pg/mL, what is the recommended systemic estrogen and progestin regimen?

Systemic Hormone Therapy for Perimenopausal Symptoms with Migraine

For this 47-year-old woman with anxiety, insomnia, worsening migraines, and low estradiol (23 pg/mL), initiate transdermal estradiol at the lowest effective dose (starting at 50 µg) with continuous progestogen (levonorgestrel IUD or continuous combined transdermal preparation), avoiding cyclical regimens that will worsen her migraine. 1

Why Transdermal Estrogen is Critical Here

The key issue is that estrogen fluctuations trigger migraine attacks, not estrogen itself. Your patient's low estradiol of 23 pg/mL indicates she's in perimenopause with erratic hormone swings—this is precisely when migraine worsens 2.

Transdermal estradiol provides stable, non-fluctuating estrogen levels that avoid the peaks and troughs of oral preparations 3, 4. This is fundamentally different from oral estrogens, which create variable serum levels and undergo first-pass hepatic metabolism, increasing inflammatory markers like C-reactive protein 1. For migraine management, this stability is everything.

Start with 50 µg transdermal estradiol and titrate to the minimum dose that controls her vasomotor symptoms (which likely underlie her insomnia and anxiety) 3. The 2015 Endocrine Society guidelines confirm transdermal preparations are easily tailored to individual needs and avoid hepatic effects 1.

Progestogen Selection: Avoid Cyclical Regimens

Cyclical progestogens will sabotage your migraine management 3. The withdrawal bleeding and hormone fluctuation from sequential regimens (estrogen 20-25 days, progestogen 12-15 days) directly contradicts the goal of hormonal stability.

Your options for continuous progestogen:

• Levonorgestrel intrauterine device (52 mg): Minimizes systemic absorption while providing endometrial protection 1, 3
• Continuous combined transdermal patch: Delivers both estradiol and progestogen daily without fluctuation 3
• Continuous oral micronized progesterone: 100-200 mg daily (though data on migraine effects are limited 3)

The levonorgestrel IUD is particularly attractive here because it provides reliable endometrial protection with minimal systemic progestogen exposure, reducing the risk of progestogen-related migraine exacerbation 3.

Evidence Supporting This Approach

A 2002 RCT comparing three HRT regimens found that continuous combined estradiol plus norethisterone resulted in the smallest increase in headache days compared to sequential regimens 5. While all HRT led to some worsening (attack frequency increased from 2.2 to 3.8 per month), the continuous combined approach was best tolerated.

More recent evidence confirms that transdermal estradiol displays a more favorable migraine profile than oral estrogens because it provides constant hormone levels 4. The 2026 narrative review on perimenopausal migraine explicitly states that continuous transdermal regimens are better tolerated than cyclical preparations 2.

Addressing Her Other Symptoms

Her anxiety and insomnia are likely multifactorial but strongly linked to:

1. Vasomotor symptoms (hot flashes/night sweats disrupting sleep) 6
2. Estrogen withdrawal effects on mood regulation 7
3. Bidirectional relationship between insomnia and anxiety 6

Stabilizing her estrogen levels with transdermal therapy should improve vasomotor symptoms, which are the primary driver of menopausal insomnia 6. The 2026 review on sleep disturbances notes that while HRT benefits for sleep are inconsistent, they're largely mediated through VMS improvement 6.

Critical Pitfalls to Avoid

Do not use oral estrogens in this patient—the fluctuating serum levels will perpetuate her migraine cycle 3, 4.

Do not prescribe sequential/cyclical progestogen—the monthly hormone withdrawal will trigger migraine attacks 3.

Do not start with high-dose estrogen—use the minimum effective dose (50 µg transdermal) and titrate up only if vasomotor symptoms persist 3, 8.

Verify she has migraine without aura—if she has migraine with aura, you still can use physiological doses of natural estrogen (unlike contraceptive-dose ethinylestradiol), but counsel about theoretical stroke risk 3.

Practical Implementation

1. Start: Transdermal estradiol 50 µg patch twice weekly
2. Add: Levonorgestrel IUD 52 mg (or continuous combined patch if she prefers single system)
3. Reassess at 3 months: Titrate estradiol dose based on vasomotor symptom control and migraine frequency
4. Monitor: Headache diary tracking attack frequency, duration, and triggers

This regimen aligns with FDA-approved preparations per Endocrine Society recommendations 1 and provides the hormonal stability essential for migraine management while addressing her anxiety, insomnia, and menopausal symptoms.